Playwright Vogel returns to campus for Ph.D.

Pulitzer Prize-winning dramatist Paula Vogel returns to campus April 12-13 for a conversation and concert reading of her most recent play, “Indecent,” and to receive her doctorate.

Mortua lingua discipulorum auxilio reviviscit*

In a new Foreign Language Across the Curriculum class with Michael Fontaine, associate professor of classics, students earn course credit while learning to converse in Latin.

Cancer cells' ability to self-repair may spawn new treatments

A Cornell research group led by associate professor Jan Lammerding is studying how cancer cells' ability to repair themselves after deformation could lead to new approaches in diagnosis and treatment.

Robert Morgan publishes new novel, poetry collection

Robert Morgan, the Kappa Alpha Professor of English in the College of Arts and Sciences, has a just-published novel, "Chasing the North Star", on the heels of a recent poetry collection, "Dark Energy."

Kip Thorne to speak on gravitational waves April 6

Kip Thorne, founder of Laser Interferometer Gravitational Wave Observatory, will give a talk on black holes and gravitational waves April 6, at 5 p.m. in Schwartz Auditorium, Rockefeller Hall.

Music department's curriculum playing a new tune

With the music department's new curriculum, students will now find a more flexible route through the program and an emphasis on improvisation and other techniques.

Add your voice to Klarman Hall time capsule

The College of Arts and Sciences hopes to capture life at Cornell today – especially the role of the humanities in our lives – as it assembles a time capsule to be buried May 26.

Metal-foam hybrid has potential in soft robotics, aeronautics

The lab of engineering professor Rob Shepherd has developed a hybrid material featuring soft metal and porous elastic polymer foam that could be used to make a morphing airplane wing.

Enzyme inhibitor looks promising against cancer

A Cornell multi-site research team has developed a chemical compound that shows promise as a oncoprotein inhibitor with broad anti-cancer activity and little effect on non-cancerous cells.